Kilitch Drugs - EGM on Aug 11, 2008
Kilitch Drugs India Ltd has informed BSE that an Extra Ordinary General Meeting (EGM) of the members of the Company will be held on August 11, 2008, inter alia, have accorded to the following:1. To increased the Authorised Share Capital of the Company from Rs 15,00,00000/- (Rupees Fifteen Crore) divided into 1,50,00,000 (One Crore Fifty Lac) Equity shares of Rs 10/- (Rupees Ten) each, to Rs 20,00,00,000/- (Rupees Twenty Crore) divided into... Kilitch Drugs - Change in Directorate
Kilitch Drugs India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 30, 2008, the following persons have been appointed as Additional Directors on the Board of the Company.1. Mr. Shailesh Chheda2. Mr. Hemang Engineer3. Mr. Deepak Shenoy4. Dr. Mahalingam Vasudevanand in respect of Mr. Pramod Mehendale, a director who has resigned from the Directorship of the Company,... Kilitch Drugs - Outcome of Board Meeting
Kilitch Drugs India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 11, 2008, inter alia, has transacted the following business:1. The Board has decided to issue, subject to all the relevant approvals, as well as in compliance of the Guidelines for Preferential Issues of Chapter XIII of the SEBI (DIP) Guidelines, 2000, an aggregate of 29 lac convertible warrants (one Warrant being convertible into... Kilitch Drugs - Updates
Kilitch Drugs India Ltd has informed BSE that there was a fire at the plant of the Company at Pawane, Navi Mumbai, on July 06, 2008. The extent of the loss caused by the fire is being assessed, and is expected to not material, and in any event the Company has adequately insured the assets at the said plant. Kilitch Drugs - Board Meeting on July 11, 2008
Kilitch Drugs India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on July 11, 2008, inter alia, to consider issue of securities to certain selected persons / entities, on preferential basis, subject to compliance of SEBI (Disclosure & Investor Protection) Guidelines, 2000. Kilitch Drugs - Notice of Postal Ballot
Kilitch Drugs India Ltd has informed BSE that the members of the Company will consider to approve by way of Postal Ballot the Resolutions as under:1. Alternation of the Articles of Association by insertion of new Articles No. 185, 186 and 187, after the existing Article No. 184, of the Articles of Association of the Company.2. Authority to the Board for mortgaging and / or creating a charge on such terms and conditions as the Board... Kilitch Drugs Board recommends final dividend
Kilitch Drugs India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 21, 2008, inter alia, has recommended a Final Dividend of 10% on the Equity Share Capital, subject to approval by Shareholders. Thus, if approved, the total dividend, inclusive of the interim dividend, for the year would aggregate to 20%. Kilitch Drugs Board to consider final dividend
Kilitch Drugs India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on June 21, 2008, inter alia, to consider the following:1. To consider the recommendation of Final Dividend the financial year ended March 31, 2008.2. To Adopt and approve the Profit and Loss Account for the year ended March 31, 2008 together with the Balance Sheet as at that date, & the Directors' Report.... Kilitch Drugs - FY 08 results by Jun 30, 2008
Kilitch Drugs India Ltd has informed BSE that the Company will publish Audited Financial results for the quarter and year ended March 31, 2008 instead of Unaudited Financial results within a period of 3 (three) months from the quarter ended March 31, 2008. Kilitch Drugs - Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
The Exchange has received the following disclosure under Regulation 13 (6) of SEBI (Prohibition of Insider Trading) Regulations, 1992: Name & Address of Director / Officer / Shareholders 27 Dec 2007Kilitch Drugs - Disclosures under Reg. 7(3) of SEBI (SAST) Regulations, 199714:07The Exchange has received the following disclosure under Regulation 7(3) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997: Name of Target company (Reporting company) ....Kilitch Drugs - Disclosures under Reg. 7(1A) of SEBI (SAST) Regulations, 199713:02The Exchange has received the following disclosure under Regulation 7(1A) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997: Name of ....30 Nov 2007Kilitch Drugs - Disclosures under Reg. 7(3) of SEBI (SAST) Regulations, 199718:16The Exchange has received the following disclosure under Regulation 7(3) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997: Name of Target company (Reporting company) ....Kilitch Drugs - Disclosures under Reg. 7(1A) of SEBI (SAST) Regulations, 199715:00The Exchange has received the following disclosure under Regulation 7(1A) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997: Name of ....Kilitch Drugs - Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199212:39The Exchange has received the following disclosure under Regulation 13 (6) of SEBI (Prohibition of Insider Trading) Regulations, 1992: Name & Address of Director / Officer / Shareholders 15 Nov 2007Kilitch Drugs - Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199214:01The Exchange has received the following disclosure under Regulation 13 (6) of SEBI (Prohibition of Insider Trading) Regulations, 1992: Name & Address of Director / Officer / Shareholders...